This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: The Translational Genomics Research Institute, University of Georgia Research Foundation Inc. Active years: 2018-2020.
Company Filing History:

Years Active: 2018-2020
Title: The Innovative Mind of Scott Schatzberg
Introduction
Scott Schatzberg is a notable inventor based in Algodones, New Mexico, recognized for his contributions to the field of medicine, particularly in the assessment of risk for developing necrotizing meningoencephalitis (NME). With two patents to his name, Schatzberg has demonstrated a commitment to advancing medical research and improving patient outcomes through innovative techniques.
Latest Patents
Scott Schatzberg's latest patents focus on groundbreaking methods for assessing the risk of developing necrotizing meningoencephalitis. The present inventions provide a method to classify subjects into risk groups for this serious disease. By assessing the presence of one or more genetic markers, such as SNPs (Single Nucleotide Polymorphisms) or risk loci, in a sample from the subject, the method enables the identification of individuals at an increased risk for NME. This classification system can ultimately guide clinical decisions and enhance patient management.
Career Highlights
Throughout his career, Schatzberg has worked with notable organizations that emphasize research and innovation. He has been associated with the Translational Genomics Research Institute, where he contributed to cutting-edge genomic research. Additionally, his work with the University of Georgia Research Foundation, Inc. has further solidified his reputation as a leading researcher and inventor in the scientific community.
Collaborations
In his journey of innovation, Scott Schatzberg has collaborated with esteemed colleagues, including Matthew Huentelman and Renee Barber. These collaborations underscore the importance of teamwork in the realm of medical research, as diverse expertise often fuels breakthrough discoveries and inventions.
Conclusion
Scott Schatzberg's innovative contributions to the understanding and assessment of necrotizing meningoencephalitis have established him as a prominent figure in the field of medical research. His dedication to identifying risk factors and improving classification methods has significant implications for patient care and treatment. As he continues to develop new inventions, the impact of his work will likely resonate within the medical community and beyond.